Monopar Therapeutics
MNPR
#8223
Rank
A$0.30 B
Marketcap
$49.62
Share price
-13.27%
Change (1 day)
924.71%
Change (1 year)

Monopar Therapeutics (MNPR) - Cash on Hand

Cash on Hand as of September 2024 : A$9.95 Million

According to Monopar Therapeutics's latest financial reports the company has A$9.95 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Monopar Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$10.66 M-44.68%
2022-12-31A$19.27 M-31.16%
2021-12-31A$28 M28.66%
2020-12-31A$21.76 M15.33%
2019-12-31A$18.87 M92.89%
2018-12-31A$9.78 M-14.96%
2017-12-31A$11.5 M300.12%
2016-12-31A$2.87 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.42 B 4,151.77%๐Ÿ‡บ๐Ÿ‡ธ USA